Janus Henderson Group PLC Ascendis Pharma A/S Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
A detailed history of Janus Henderson Group PLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,380,382 shares of ASND stock, worth $683 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
4,380,382
Previous 4,186,694
4.63%
Holding current value
$683 Million
Previous $625 Million
3.55%
% of portfolio
0.32%
Previous 0.33%
Shares
23 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
60.2MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.58 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$862 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$795 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$694 Million0.98% of portfolio
-
Capital International Investors Los Angeles, CA2.86MShares$446 Million0.08% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.7B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...